oral direct thrombin inhibitor (Oriens Life Sciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameoral direct thrombin inhibitor (Oriens Life Sciences)
Drug Alias Nameoral direct thrombin inhibitor (Matrix Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IIa inhibitors
TargetsProthrombin
Therapy Area/IndicationsThromboembolismStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMatrix Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOriens Life Sciences LtdMatrix Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsThromboembolismStroke

Other Information

ATC CodeN/A
Related LinksN/A